Figure 1.

Variation in LVEF over time in women treated and not treated with bromocriptine. Shown is the variation in LVEF over time for each woman (grey lines) and the mean ± standard deviation (black lines) in women treated (panel A) and not treated (panel B) with bromocriptine. For the whole cohort, the median time from baseline to 6 months and from baseline to longest available follow‐up was 6 (3) months and 25 (61) months, respectively. P‐values were derived from the random growth model performed on the complete‐case cohort, representing the slope of the variation in LVEF over time. Women for whom both LVEF follow‐up values were missing (n = 9) were excluded from this plot, among whom two women had death surrogates before the 6 month follow‐up (heart transplant and left ventricular assist device implantation). The total number of LVEF values available in patients free of death, heart transplant, or left ventricular assist device was 76 at baseline, 66 at 6 months, and 61 at last follow‐up. LVEF, left ventricular ejection fraction; PPCM, peripartum cardiomyopathy.